Hanieh Safari

Hanieh Safari

Auto-generated profile, based on publicly available information

Hanieh Safari

Department of Chemical Engineering, University of Michigan, Ann Arbor, MI 48109, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
HSHanieh Safari
Hanieh Safari
WKWilliam J. Kelley
William J. Kelley
ESEiji Saito
Eiji Saito
NKNicholas Kaczorowski
Nicholas Kaczorowski
LCLauren Carethers
Lauren Carethers
OAOmolola Eniola Adefeso
Omolola Eniola Adefeso
Neutrophils find rods more attractive than spheres.

4 December 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
HSHanieh Safari
Hanieh Safari
NKNicholas Kaczorowski
Nicholas Kaczorowski
MFMichael L. Felder
Michael L. Felder
EBEmma R. Brannon
Emma R. Brannon
MVMita Varghese
Mita Varghese
OAOmolola Eniola Adefeso
Omolola Eniola Adefeso
We describe a novel gold-templating method for fabricating stable, biodegradable, bile salt microparticles with controlled geometry.

1 May 2018 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
HSHanieh Safari
Hanieh Safari
RAReheman Adili
Reheman Adili
MHMichael Holinstat
Michael Holinstat
OAOmolola Eniola Adefeso
Omolola Eniola Adefeso

1 November 2023 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
HSHanieh Safari
Hanieh Safari
SMShohreh Mashayekhan
Shohreh Mashayekhan
: Mood disorders are the leading cause of disability worldwide and their incidence has significantly increased after the COVID-19 pandemic. Despite the continuous surge in the number of people diagnosed with psychiatric disorders, the treatment methods for these conditions remain limited. A significant number of people either do not respond to therapy or discontinue the drugs due to their severe side effects. Therefore, alternative therapeutic interventions are needed. Previous studies have shown a correlation between immunological alterations and the occurrence of mental health disorders, yet immunomodulatory therapies have been barely investigated for combating psychiatric conditions. In this article, we have reviewed the immunological alterations that occur during the onset of mental health disorders, including microglial activation, an increased number of circulating innate immune cells, reduced activity of natural killer cells, altered T cell morphology and functionality, and an increased secretion of pro-inflammatory cytokines. This article also examines key studies that demonstrate the therapeutic efficacy of anti-inflammatory medications in mental health disorders. These studies suggest that immunomodulation can potentially be used as a complementary therapy for controlling psychiatric conditions after careful screening of candidate drugs and consideration of their efficacy and side effects in clinical trials.

28 May 2024 in Chemical Engineering Science
Verified
Journal Article
Closed access
MSMorteza Safari
Morteza Safari
PAPezhman Abbasi
Pezhman Abbasi
SMSeyedAli Momeni
SeyedAli Momeni
MFMahdieh Shahrabi Farahani
Mahdieh Shahrabi Farahani
HSHanieh Safari
Hanieh Safari

20 February 2026 in Science Advances
Verified
Journal Article
Open access
OAOluwaseun D. Akanbi
Oluwaseun D. Akanbi
MFMichael L. Felder
Michael L. Felder
DKDaniel Kupor
Daniel Kupor
JFJiachen Feng
Jiachen Feng
LCLuana Janaína de Campos
Luana Janaína de Campos
OAOmolola Eniola Adefeso
Omolola Eniola Adefeso
Steroids, specifically bile salts and corticosteroids, treat bile synthesis disorders, liver dysfunction, and inflammation. However, these water-soluble steroid drugs are rapidly cleared from the desired sites of action in the body, necessitating multiple doses. Therefore, the development of particle-based steroid medications that offer elongated therapeutic activity is of paramount medical importance. Accordingly, steroid microparticles were developed via three fabrication processes in this work, where a metal or an organic acid facilitates steroid microparticle formation. Particles fabricated using these methods exhibit consistent shape, size, and crystallinity. Furthermore, results from our coarse-grained computational model show that hydrogen bonding dictates steroid monomer-monomer interactions that determine overall particle shape and size. In addition, we demonstrate the ability to induce steroid particle formation and tune the morphology of steroid drug particles by replacing the C21 side group (tail) with chemical analogs. Thus, this study opens opportunities for the clinical translation of particle-based steroid therapeutics as an alternative to the current steroid drug formulations.